Skip to main content
Top
Published in: BMC Gastroenterology 1/2012

Open Access 01-12-2012 | Research article

The impact of Irritable Bowel Syndrome on health-related quality of life: a Singapore perspective

Authors: Yu Tien Wang, Hwee Yong Lim, David Tai, Thinesh L Krishnamoorthy, Tira Tan, Sylvaine Barbier, Julian Thumboo

Published in: BMC Gastroenterology | Issue 1/2012

Login to get access

Abstract

Background

Irritable bowel syndrome (IBS) is a common gastrointestinal disorder. The prevalence of IBS in Asian countries varies from 2.9% to 15.6%. IBS does not result in increased mortality, but is associated with psychological distress and disruption of work and sleep. Consequently, the evaluation of health-related quality of life (HRQoL) is an important outcome measure for patients with IBS since it provides a holistic assessment of the patient's emotional, social and physical function. However, some HRQoL tools can be time-consuming to apply. EQ-5D is a brief HRQoL tool which has been validated in the Western IBS population but has thus far not been used in Asia. This study was conducted to determine whether persons with self-reported symptoms that met the Rome III criteria for IBS had a poorer quality of life than those without these symptoms. We also aimed to determine which specific aspects of quality of life were most affected and whether any risk factors distinguished those with and without IBS.

Methods

Self-administered questionnaires which included the Rome III diagnostic questionnaire modules for IBS and the EQ-5D questionnaire were obtained from participants of a health symposium in Singapore on 31th October 2010. IBS was diagnosed based on the Rome III Criteria. The main outcome measure was the EQ-5D index score. The relationship between the presence of IBS and the EQ-5D index score, individual dimensions of EQ-5D and demographic risk factors were examined.

Results

449 completed questionnaires were analyzed. The mean EQ-5D index score for IBS was 0.739 which was a significant reduction compared to non-IBS participants [−0.11 (95% CI: -0.15 to −0.07), p < 0.001]. Multivariate analysis showed that IBS was significantly associated with younger age and higher education level. Of the five EQ-5D dimensions, IBS sufferers were significantly affected in mobility, anxiety or depression, usual activity and pain. There was a "dose related" increase in likelihood of having IBS with increased severity of pain and anxiety or depression.

Conclusion

IBS sufferers have significantly poorer quality of life. Assessment of HRQoL in IBS using the EQ-5D should be considered in further studies and routine clinical practice.
Literature
1.
go back to reference Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, Chua AS, Lu CL, Goh KL, Kositchaiwat C, Makharia G, Park HJ, Chang FY, Fukudo S, Choi MG, Bhatia S, Ke M, Hou X, Hongo M: Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol. 2010, 25 (7): 1189-1205.CrossRefPubMed Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, Chua AS, Lu CL, Goh KL, Kositchaiwat C, Makharia G, Park HJ, Chang FY, Fukudo S, Choi MG, Bhatia S, Ke M, Hou X, Hongo M: Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol. 2010, 25 (7): 1189-1205.CrossRefPubMed
2.
go back to reference El-Serag HB, Olden K, Bjorkman D: Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther. 2002, 16 (6): 1171-1185. 10.1046/j.1365-2036.2002.01290.x.CrossRefPubMed El-Serag HB, Olden K, Bjorkman D: Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther. 2002, 16 (6): 1171-1185. 10.1046/j.1365-2036.2002.01290.x.CrossRefPubMed
3.
go back to reference Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA: The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000, 119 (3): 654-660. 10.1053/gast.2000.16484.CrossRefPubMed Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA: The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000, 119 (3): 654-660. 10.1053/gast.2000.16484.CrossRefPubMed
4.
go back to reference Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM: An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009, 104 (Suppl 1): S1-S35.PubMed Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM: An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009, 104 (Suppl 1): S1-S35.PubMed
5.
go back to reference Hayes V, Morris J, Wolfe C, Morgan M: The SF-36 health survey questionnaire: is it suitable for use with older adults?. Age Ageing. 1995, 24 (2): 120-125. 10.1093/ageing/24.2.120.CrossRefPubMed Hayes V, Morris J, Wolfe C, Morgan M: The SF-36 health survey questionnaire: is it suitable for use with older adults?. Age Ageing. 1995, 24 (2): 120-125. 10.1093/ageing/24.2.120.CrossRefPubMed
6.
go back to reference Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001, 33 (5): 337-343. 10.3109/07853890109002087.CrossRefPubMed Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001, 33 (5): 337-343. 10.3109/07853890109002087.CrossRefPubMed
7.
go back to reference Bushnell DM, Martin ML, Ricci JF, Bracco A: Performance of the EQ-5D in patients with irritable bowel syndrome. Value Health. 2006, 9 (2): 90-97. 10.1111/j.1524-4733.2006.00086.x.CrossRefPubMed Bushnell DM, Martin ML, Ricci JF, Bracco A: Performance of the EQ-5D in patients with irritable bowel syndrome. Value Health. 2006, 9 (2): 90-97. 10.1111/j.1524-4733.2006.00086.x.CrossRefPubMed
8.
go back to reference Wee HL, Loke WC, Li SC, Fong KY, Cheung YB, Machin D, Luo N, Thumboo J: Cross-cultural adaptation and validation of Singapore Malay and Tamil versions of the EQ-5D. Ann Acad Med Singapore. 2007, 36 (6): 403-408.PubMed Wee HL, Loke WC, Li SC, Fong KY, Cheung YB, Machin D, Luo N, Thumboo J: Cross-cultural adaptation and validation of Singapore Malay and Tamil versions of the EQ-5D. Ann Acad Med Singapore. 2007, 36 (6): 403-408.PubMed
9.
go back to reference Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J: Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore. Ann Acad Med Singapore. 2003, 32 (5): 685-690.PubMed Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J: Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore. Ann Acad Med Singapore. 2003, 32 (5): 685-690.PubMed
10.
go back to reference Drossman D, Corazziari E, Delvaux M, Spiller R, Talley J, Thompson WG, Whitehead WE: Rome III: The Functional Gastrointestinal Disorders. 3rd ed.  . Edited by: Drossman D, Corazziari E, Delvaux M, Spiller R, Talley J, Thompson WG, Whitehead WE. 2006, Degnon Associates Inc, Mclean, VA Drossman D, Corazziari E, Delvaux M, Spiller R, Talley J, Thompson WG, Whitehead WE: Rome III: The Functional Gastrointestinal Disorders. 3rd ed.  . Edited by: Drossman D, Corazziari E, Delvaux M, Spiller R, Talley J, Thompson WG, Whitehead WE. 2006, Degnon Associates Inc, Mclean, VA
11.
go back to reference Group E: EuroQoL- a new facility for the measurement of health-related quality of life. Health Policy. 1990, 16: 199-208.CrossRef Group E: EuroQoL- a new facility for the measurement of health-related quality of life. Health Policy. 1990, 16: 199-208.CrossRef
12.
go back to reference Szende A, Oppe M, Devlin NJ, EuroQol Group : EQ-5D value sets : inventory, comparative review, and user guide. . 2007, Springer, Dordrecht, 102-CrossRef Szende A, Oppe M, Devlin NJ, EuroQol Group : EQ-5D value sets : inventory, comparative review, and user guide. . 2007, Springer, Dordrecht, 102-CrossRef
13.
go back to reference Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, Platts M, Walters SJ: Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. PharmacoEconomics. 2002, 20 (7): 455-462. 10.2165/00019053-200220070-00003.CrossRefPubMed Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, Platts M, Walters SJ: Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. PharmacoEconomics. 2002, 20 (7): 455-462. 10.2165/00019053-200220070-00003.CrossRefPubMed
14.
go back to reference Sullivan PW, Ghushchyan V: Preference-Based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006, 26 (4): 410-420. 10.1177/0272989X06290495.CrossRefPubMedPubMedCentral Sullivan PW, Ghushchyan V: Preference-Based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006, 26 (4): 410-420. 10.1177/0272989X06290495.CrossRefPubMedPubMedCentral
15.
go back to reference Gwee KA, Wee S, Wong ML, Png DJ: The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community. Am J Gastroenterol. 2004, 99 (5): 924-931. 10.1111/j.1572-0241.2004.04161.x.CrossRefPubMed Gwee KA, Wee S, Wong ML, Png DJ: The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community. Am J Gastroenterol. 2004, 99 (5): 924-931. 10.1111/j.1572-0241.2004.04161.x.CrossRefPubMed
16.
go back to reference Ho KY, Kang JY, Seow A: Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol. 1998, 93 (10): 1816-1822. 10.1111/j.1572-0241.1998.00526.x.CrossRefPubMed Ho KY, Kang JY, Seow A: Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol. 1998, 93 (10): 1816-1822. 10.1111/j.1572-0241.1998.00526.x.CrossRefPubMed
17.
go back to reference Si JM, Wang LJ, Chen SJ, Sun LM, Dai N: Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol. 2004, 10 (7): 1059-1064.PubMedPubMedCentral Si JM, Wang LJ, Chen SJ, Sun LM, Dai N: Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol. 2004, 10 (7): 1059-1064.PubMedPubMedCentral
18.
go back to reference Guthrie E, Barlow J, Fernandes L, Ratcliffe J, Read N, Thompson DG, Tomenson B, Creed F: Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome. Psychosom Med. 2004, 66 (4): 578-582. 10.1097/01.psy.0000128899.22514.c0.CrossRefPubMed Guthrie E, Barlow J, Fernandes L, Ratcliffe J, Read N, Thompson DG, Tomenson B, Creed F: Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome. Psychosom Med. 2004, 66 (4): 578-582. 10.1097/01.psy.0000128899.22514.c0.CrossRefPubMed
19.
go back to reference Shah SS, Bhatia SJ, Mistry FP: Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol. 2001, 20 (3): 103-106.PubMed Shah SS, Bhatia SJ, Mistry FP: Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol. 2001, 20 (3): 103-106.PubMed
20.
go back to reference Gwee KA, Lu CL, Ghoshal UC: Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol. 2009, 24 (10): 1601-1607. 10.1111/j.1440-1746.2009.05984.x.CrossRefPubMed Gwee KA, Lu CL, Ghoshal UC: Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol. 2009, 24 (10): 1601-1607. 10.1111/j.1440-1746.2009.05984.x.CrossRefPubMed
Metadata
Title
The impact of Irritable Bowel Syndrome on health-related quality of life: a Singapore perspective
Authors
Yu Tien Wang
Hwee Yong Lim
David Tai
Thinesh L Krishnamoorthy
Tira Tan
Sylvaine Barbier
Julian Thumboo
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2012
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-12-104

Other articles of this Issue 1/2012

BMC Gastroenterology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.